These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 9437199

  • 41. Phospholipase A(2) activity in non-glycated and glycated low density lipoproteins.
    Sakurai T, Yamamoto Y, Baba N, Nakano M.
    Biochim Biophys Acta; 1996 May 31; 1301(1-2):85-9. PubMed ID: 8652655
    [Abstract] [Full Text] [Related]

  • 42. Oxidized LDL contains inflammatory PAF-like phospholipids.
    Marathe GK, Prescott SM, Zimmerman GA, McIntyre TM.
    Trends Cardiovasc Med; 2001 May 31; 11(3-4):139-42. PubMed ID: 11686003
    [Abstract] [Full Text] [Related]

  • 43. Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation.
    MacRitchie AN, Gardner AA, Prescott SM, Stafforini DM.
    FASEB J; 2007 Apr 31; 21(4):1164-76. PubMed ID: 17210780
    [Abstract] [Full Text] [Related]

  • 44. Human plasma platelet-activating factor acetylhydrolase. Purification and properties.
    Stafforini DM, Prescott SM, McIntyre TM.
    J Biol Chem; 1987 Mar 25; 262(9):4223-30. PubMed ID: 3558407
    [Abstract] [Full Text] [Related]

  • 45. Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.
    Sasabe N, Keyamura Y, Obama T, Inoue N, Masuko Y, Igarashi Y, Aiuchi T, Kato R, Yamaguchi T, Kuwata H, Iwamoto S, Miyazaki A, Hara S, Yoshikawa T, Itabe H.
    Lipids Health Dis; 2014 Mar 14; 13():48. PubMed ID: 24625108
    [Abstract] [Full Text] [Related]

  • 46. Activation of PAF receptor by oxidised LDL in human monocytes stimulates chemokine releases but not urokinase-type plasminogen activator expression.
    Beaudeux JL, Said T, Ninio E, Ganné F, Soria J, Delattre J, Soria C, Legrand A, Peynet J.
    Clin Chim Acta; 2004 Jun 14; 344(1-2):163-71. PubMed ID: 15149885
    [Abstract] [Full Text] [Related]

  • 47. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
    Dulioust A, Hilliquin P, Menkes CJ, Benveniste J, Arnoux B.
    Scand J Rheumatol; 1992 Jun 14; 21(4):161-4. PubMed ID: 1529281
    [Abstract] [Full Text] [Related]

  • 48. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia.
    Jehle R, Schlame M, Büttner C, Frey B, Sinha P, Rüstow B.
    Biochim Biophys Acta; 2001 May 31; 1532(1-2):60-6. PubMed ID: 11420174
    [Abstract] [Full Text] [Related]

  • 49. Activity of platelet-activating factor acetylhydrolase exists in red cell membrane.
    Yoshida H, Satoh K, Imaizumi T.
    Am J Hematol; 1992 May 31; 40(1):61-3. PubMed ID: 1566749
    [Abstract] [Full Text] [Related]

  • 50. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers.
    Imaizumi T, Satoh K, Yoshida H, Kawamura Y, Hiramoto M, Koyanagi M, Takamatsu S, Takamatsu M.
    Heart Vessels; 1990 May 31; 5(2):81-6. PubMed ID: 2354992
    [Abstract] [Full Text] [Related]

  • 51. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.
    MacPhee CH, Moores KE, Boyd HF, Dhanak D, Ife RJ, Leach CA, Leake DS, Milliner KJ, Patterson RA, Suckling KE, Tew DG, Hickey DM.
    Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):479-87. PubMed ID: 10024526
    [Abstract] [Full Text] [Related]

  • 52. Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver.
    Marathe GK, Harrison KA, Roberts LJ, Morrow JD, Murphy RC, Tjoelker LW, Prescott SM, Zimmerman GA, McIntyre TM.
    J Lipid Res; 2001 Apr 01; 42(4):587-96. PubMed ID: 11290831
    [Abstract] [Full Text] [Related]

  • 53. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase.
    Tarbet EB, Stafforini DM, Elstad MR, Zimmerman GA, McIntyre TM, Prescott SM.
    J Biol Chem; 1991 Sep 05; 266(25):16667-73. PubMed ID: 1653245
    [Abstract] [Full Text] [Related]

  • 54. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C, Postiglione A, Triggiani M, Corso G, Palumbo G, Carbone V, Ruocco A, Ambrosio G, Montefusco S, Malorni A, Condorelli M, Chiariello M.
    Atherosclerosis; 1995 Dec 05; 118(2):259-73. PubMed ID: 8770320
    [Abstract] [Full Text] [Related]

  • 55. Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery.
    Tsoukatos DC, Brochériou I, Moussis V, Panopoulou CP, Christofidou ED, Koussissis S, Sismanidis S, Ninio E, Siminelakis S.
    J Lipid Res; 2008 Oct 05; 49(10):2240-9. PubMed ID: 18587071
    [Abstract] [Full Text] [Related]

  • 56. Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery.
    Stephens CJ, Graham RM, Yadava OP, Leong LL, Sturm MJ, Taylor RR.
    Cardiovasc Res; 1992 Jan 05; 26(1):25-31. PubMed ID: 1516109
    [Abstract] [Full Text] [Related]

  • 57. Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids.
    Chang PY, Luo S, Jiang T, Lee YT, Lu SC, Henry PD, Chen CH.
    Circulation; 2001 Jul 31; 104(5):588-93. PubMed ID: 11479258
    [Abstract] [Full Text] [Related]

  • 58. Platelet-activating factor acetylhydrolase activity in seminal plasma from the bull, stallion, rabbit, and rooster.
    Hough SR, Parks JE.
    Biol Reprod; 1994 Apr 31; 50(4):912-6. PubMed ID: 8199270
    [Abstract] [Full Text] [Related]

  • 59. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
    Svetlov SI, Howard KM, Miwa M, Flickinger BD, Olson MS.
    Arch Biochem Biophys; 1996 Mar 01; 327(1):113-22. PubMed ID: 8615681
    [Abstract] [Full Text] [Related]

  • 60. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats.
    Wójcicka G, Zaręba M, Warpas A, Jamroz-Wiśniewska A, Rusek M, Czechowska G, Bełtowski J.
    Eur J Pharmacol; 2019 May 05; 850():180-189. PubMed ID: 30768981
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.